Introduction
In our previous study (Ito et al., 1974) , L-glutamine deprivation, or addition of L-glutaminase into culture medium, was found to result in suppression of Sendai virus replication. Specific amino acids have been shown to be essential for replication of some viruses, for example L-arginine for herpesvirus (Tankersley, 1964; Inglis, 1968; Spring et al., 1969; Courteney et al., 1970) , adenovirus (Rouse & Schlesinger, 1967) , respiratory syncytial virus (RSV) (Levine et al., 1971) and Newcastle disease virus (NDV) (Iinuma et al., 1973) , L-lysine for reovirus (Loh & Oie, 1969) , phenylalanine for RSV (Levine et al., 1971) ; L-serine for NDV (Ito et al., 1969) and methionine for measles virus (Hirayama et al., 1985) . Given these observations, either specific antagonists against some amino acids, or specific inhibitors of enzymes responsible for the metabolism of some amino acids might be candidates for anti-virus substances.
6-Diazo-5-oxo-L-norleucine (L-DON) was isolated from culture broths of an unidentified streptomyces that showed growth-inhibitory activity towards bacteria, yeasts and some tumours (Ehrlich et al., 1956 ). This substance was found to be a specific inhibitor of ~-glutamyl transpeptidase (Hartman & McGrath, 1973; Novogrodsky et al., 1977) . In this study L-DON inhibited the replication of some viruses, and the mechanisms by which the substance inhibited growth of human parainfluenza virus type 2 (HPIV-2) were investigated.
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Methods
Cells and viruses. Vero, LLCMK2, BHK and primary monkey kidney cells were grown in Eagle's minimum essential medium (MEM) supplemented with 5 % calf serum and 2% tryptose phosphate broth. HPIV-2 (Toshiba strain), mumps and vesicular stomatitis viruses (VSV) were used in this study. Their infectivities were determined by plaque assay on Vero cell monolayers and expressed as p.f.u, per ml.
Isotopic labelling of infected cells.
Isotopic labelling of the infected cells was carried out according to the method described previously (Ito et al., 1987) . Vero cells were infected with HPIV-2 at an m.o.i, of 2 p.f.u, per cell. At 15 h after infection, the cells were depleted of methionine and then labelled with [3sS]methionine (40 ktCi/0.5 ml) for 5h.
Radioimmunoprecipitation and SDS-PAGE.
Radioimmunoprecipitation and SDS-PAGE were done as described previously (Ito et al., 1985) .
Antibodies and immunofluorescence staining. Monoclonal antibodies (MAbs) directed against the HN, F, NP, P or M proteins of HPIV-2 were used for immunofluorescence staining.
Infected cells were fixed with formaldehyde (3.7~) for 15 min and then treated with Triton X-100 (0.05~). The fixed cells were immunostained with each MAb and then with isothiocyanate-labelled antimouse immunoglobulin rabbit serum, as described previously (Tsurudome et al., 1986) .
Northern blot hybn2tization. Total RNA was directly extracted from HPIV-2-infected Vero cells by phenol. The RNA was then blotted onto a nylon membrane (Amersham) and fixed by irradiation with u.v. light. The membrane was incubated with a 3zp-labelled eDNA probe of either HPIV-2 NP or HN mRNA at 42 °C for I8 h (Kawano et al., 1989 
Results
Effect of various concentrations of L-DON on HPIV-2 replication in Vero cells
Vero cells were infected with HPIV-2, mumps virus or VSV at an m.o.i, of 2. At 1 h of incubation at 37 °C, infected cells were washed four times with MEM and then incubated with MEM containing various concentrations of L-DON. After incubation at 37 °C for 30, 30 or 15 h, respectively, the culture fluids were harvested and virus infectivity titres were assayed. As shown in Table 1 
Effects of L-DON on HPIV-2 replication in other cells
HPIV-2 replication in other cells incubated with L-DON was also studied; LLCMK2, primary monkey kidney and BHK cells were infected with HPIV-2 at an m.o.i, of 2, and 26 h after incubation with or without L-DON (1 or 10 mM), virus yields were measured. In all the cells tested, HPIV-2 replication was suppressed by L-DON at almost the same rate as that in Vero cells (data not shown).
Effects of removal of L-DON on HPIV-2 growth
HPIV-2-infected Vero cells were incubated in the presence or absence of L-DON (2 mM) and L-DON was removed from the medium 8 h after infection. As shown in Fig. 2 , virus replication was restored and the kinetics of virus yields was identical to that in the absence of L-DON, with a delay of about 8 h, indicating that the inhibitory effect of L-DON is reversible and its effect is exerted relatively early during virus replication.
Effect of synthesis of virus-specific polypeptides in HPIV-2-infected Vero cells treated or untreated with L-DON
For the analysis of synthesis of virus-specific polypeptides, HPIV-2-infected Vero cells were incubated in the presence or absence of 2 mM-L-DON. After 15 h of incubation, the cells were labelled for 5 h with [35S]methionine and the cell extracts analysed by SDS-PAGE, followed by fluorography (Fig. 3) . As HPIV-2 infection hardly affected host cell protein synthesis, immunoprecipitation was a necessary prerequisite for identification of virus-specific polypeptides. In infected cells untreated with L-DON, major virus-specific polypeptides, namely HN, NP, F1 and M, were found (Fig. 3,  lane 1) . On the other hand, when infected cells were incubated with L-DON, less NP protein alone was detected and the glycoproteins (HN and F) and M protein could not be found (Fig. 3, lane 2) . The P protein was poorly detected in infected Vero cells by the immunoprecipitation assay; the reason for this is not clear . Furthermore, the band of FI protein overlapped the band of P protein in Fig. 3 . The P protein was therefore analysed with immunostaining, using MAbs as described later. L-DON (2 mM) had little influence on cellular macromolecular synthesis (data not shown).
Subsequently, the synthesis of HPIV-2-specific polypeptides and their distribution in infected cells were examined by indirect immunofluorescence staining using MAbs directed against the NP or HN polypeptides of HPIV-2. At 14, 18 and 22 h after incubation of HPIV-2-infected Vero cells, in the presence or absence of L- DON (2 mM), the cells were fixed with formaldehyde (3"7~o) and then treated with Triton X-100 (0.05~). When the infected Vero cells untreated with L-DON were immunostained with either anti-NP (Fig. 4a to c) or anti-HN ( Fig. 4g to i) MAbs, fluorescence was observed in the cytoplasm at 14 h post-infection (p.i.) and thereafter fluorescence was strongly stained in polykaryocytes. Conversely, when the infected cells treated with L-DON were stained with anti-HN MAb, fluorescence could scarcely be detected throughout virus replication ( Fig. 4j to/) , although a few antigen-positive cells were found at 18 h p.i. (Fig. 4k) . Anti-NP MAbs showed positive fluorescence at 14 h p.i., fluorescence increased slightly until 18 h p.i. and then decreased ( Fig.  4d to f) . The infected cells fixed at 22 h p.i. were also stained with MAbs directed against the P, M or F proteins of HPIV-2. The P and M antigens were detected by anti-P and anti-M MAbs, whereas anti-F MAbs did not show any fluorescence in the cells incubated with L-DON (Fig. 5) . These findings show that synthesis of virus-specific polypeptides, especially glycoproteins, may be suppressed by L-DON. Another possibility is that L-DON may inhibit glycosylation of the viral glycoproteins and the resultant non-glycosylated virus glycoproteins may be much more unstable. 
Synthesis of virus messenger RNA in virus-infected cells
We tried to test whether the decrease in amounts of virusspecific polypeptides was due to inhibition of synthesis of virus m R N A . R N A fractions were isolated from HPIV-2-infected Vero cells treated or untreated with L-D O N (2 mM) and each 2 ~tg of R N A was dotted onto a nylon membrane. Subsequently, R N A s fixed on the m e m b r a n e were hybridized with a 32p-labelled H P I V -2 
Compensation of other substances for inhibitory effects of L-DON
In our previous study (Ito et al., 1974) when either Lglutamic acid, L-aspartic acid or L-alanine was added into L-glutamine-deprived medium, virus replication was restored. Therefore, the antagonistic effects of other substances, including these non-essential amino acids, on L -D O N (2 m u ) were studied. L-Glutamine (100 mM) a n d L-alanine ( 1 0 0 mM) could partly reverse the inhibitory effect of L -D O N on virus growth, but Lglutamic acid, L-aspartic acid, inosine, glucosamine, maleic acid and pyruvate had no ability to restore virus replication in the presence o f L -D O N (Table 2) . 
Discussion
L-DON, an inhibitor of y-glutamyl transpeptidase, inhibited replication of HPIV-2, mumps virus and VSV.
In particular replication of HPIV-2 was pronouncedly suppressed. L-DON also suppressed the growth of virus in the other three cell types, indicating that its effect is not cell-specific. Goldstein & Guskey (1984) also reported that poliovirus and VSV replication was disturbed in the presence of L-DON. This finding suggests that glutamine antagonists are good candidates for antiviral substances. When L-DON was added into culture medium prior to, or simultaneously with, HPIV-2 adsorption, the virusinhibitory effect was maximal. Furthermore, removal of L-DON resulted in restoration of virus growth and the kinetics of virus yields after removal of L-DON was identical to that in the absence of the drug, although their recovery had a delay almost as long as the time during which L-DON had been present. These findings indicate that the L-DON-sensitive step(s) is relatively early during virus replication. When HPIV-2-infected Vero cells were incubated in the presence of L-DON, proteins HN and F were scarcely detected by immunofluorescence staining and radioimmunoprecipitation, whereas HN mRNA was detected by Northern blot hybridization. NP mRNA and polypeptide were clearly detected by Northern blot hybridization and immunofluorescence staining or radioimmunoprecipitation, respectively. The P and M proteins were immunostained in infected ceils incubated with L-DON using MAbs directed against these proteins. These observations suggest that L-DON selectively decreased the amounts of glycoproteins in comparison with those of internal proteins. In virusinfected cells untreated with L-DON, either HN or NP mRNA increased until 24 h p.i., whereas in cells treated with the drug the amounts of both the mRNAs were maximal at 16 h p.i. and thereafter decreased rapidly. In addition, the amount of HN mRNA at 8 h p.i. was almost the same as that in cells untreated with L-DON. It is inferred that primary transcription progresses normally, whereas secondary and subsequent transcription is relatively inhibited in infected cells treated with L-DON.
L-DON is known to interfere with glycoprotein synthesis by inhibiting production of glucosamine and to inhibit nucleic acid production by interference with amino transfer reactions during purine and pyrimidine synthesis (King et al., 1978) . These inhibition mechanisms may also be involved in the suppression of HPIV-2 growth. Thus, L-DON might inhibit glycosylation of the virus glycoproteins and this lack of glycosylation may cause them to become unstable. The observation that Lglutamine and L-alanine reversed the activity of L-DON is consistent with the report by Goldstein & Guskey (1984) and our report on glutamine deprivation (Ito et al., 1974) .
Other glutamine antagonists will be tested for antiviral activity and we will attempt to detect new types of antiviral drugs.
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